Dernières nouvelles pour Affirm Holdings (NASDAQ:AFRM) Stock

AFFIRM HOLDINGS INC

Affirm Holdings

Affirm Holdings Inc offers a platform for digital and mobile-first commerce. It comprises a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The firm generates its revenue from merchant networks, and through virtual card networks among others. Geographically, it generates a majority share of its revenue from the United States.

Affirm Holdings, Inc. - Class A Common Stock

Affirm Holdings Inc

Alphaform AG

ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) reported quarterly losses of $(1.97) per share which missed the analyst consensus estimate of $(1.37) by 43.8 percent. This is a 2088.89 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $2.850 million which missed the analyst consensus estimate of $5.794 million by 50.81 percent. This is a 1.93 percent increase over sales of $2.796 million the same period last year.

Earnings

Earnings Misses

News

ESS Tech Q4 2024 GAAP EPS $(1.97) Misses $(1.37) Estimate, Sales $2.850M Miss $5.794M Estimate

BHST

BioHarvest Sciences Inc. - Common Stock Q4 2024 Adj EPS $(0.17) Misses $(0.15) Estimate, Sales $7.30M Miss $9.31M Estimate

ROYAL OAK, Mich., March 31, 2025 /PRNewswire/ -- Agree Realty Corporation (NYSE:&nbsp;ADC) (the "Company") today announced the establishment of its inaugural commercial paper program. The program allows the Company, through its subsidiary, Agree Limited Partnership (the "Issuer"), to issue up to $625 million of short-term, unsecured commercial paper notes. The notes will be sold under customary terms in the United States commercial paper note market and will rank pari passu with all the Issuer's other senior unsecured indebtedness. The notes will be fully and unconditionally guaranteed by the Company and certain of its subsidiaries. Note proceeds will be used for general corporate purposes.
The commercial paper program further diversifies and strengthens the Company's balance sheet by providing another source of short-term capital. The Company expects to realize cost benefits in the commercial paper market versus its $1.25 billion revolving credit facility, and it expects to use its revolving credit facility as a liquidity backstop for the repayment of the notes issued under the commercial paper program.
The notes and guarantees to be offered under the commercial paper program have not been and will not be registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the notes under the Issuer's commercial paper program.

Agree Realty Establishes $625M Commercial Paper Program

Aqua Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQMS#NASDAQ">AQMS</a>) reported quarterly losses of $(3.83) per share which missed the analyst consensus estimate of $(3.00) by 27.67 percent.

AQMS

Aqua Metals FY 2024 GAAP EPS $(3.83) Misses $(3.00) Estimate

Progress Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRGS#NASDAQ">PRGS</a>) reported quarterly earnings of $1.31 per share which beat the analyst consensus estimate of $1.06 by 23.58 percent. This is a 4.8 percent increase over earnings of $1.25 per share from the same period last year. The company reported quarterly sales of $238.01 million which beat the analyst consensus estimate of $235.63 million by 1.01 percent. This is a 28.88 percent increase over sales of $184.69 million the same period last year.

Earnings Beats

PRGS

Progress Software Q1 2025 Adj EPS $1.31 Beats $1.06 Estimate, Sales $238.01M Beat $235.63M Estimate

VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) reported quarterly sales of $1.200 million which missed the analyst consensus estimate of $1.796 million by 33.18 percent.

VNRX

VolitionRX FY Sales $1.200M Miss $1.796M Estimate

LPRO

Open Lending Q4 2024 GAAP EPS $1.21 Beats $0.02 Estimate, Sales $(56.90M) Miss $23.65M Estimate

Biotech

General

CNTB

Connect Biopharma Reports Data From Global Phase 2 Trial Of Rademikibart In Patients With Moderate-To-Severe Uncontrolled Asthma

Talphera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLPH#NASDAQ">TLPH</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.16) by 56.25 percent. This is a 72 percent increase over losses of $(0.25) per share from the same period last year.

TLPH

Talphera Q4 2024 GAAP EPS $(0.07) Beats $(0.16) Estimate

Guidance

SONM

Sonim Technologies FY24 EPS ($7.13) Down From ($0.02) YoY; Revenue $58.29M Down From $93.63M YoY.

Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) reported quarterly losses of $(0.29) per share. This is a 81.88 percent increase over losses of $(1.60) per share from the same period last year. The company reported quarterly sales of $20.23 million which beat the analyst consensus estimate of $17.40 million by 16.24 percent. This is a 28.82 percent increase over sales of $15.70 million the same period last year.

Spruce Power Holding Corporation Class A Common Stock

SPRU

Spruce Power Holding Q4 2024 GAAP EPS $(0.29) Up From $(1.60) YoY, Sales $20.23M Beat $17.40M Estimate

Rani Therapeutics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RANI#NASDAQ">RANI</a>) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is unchanged from the same period last year.

RANI

Rani Therapeutics Hldgs Q4 2024 GAAP EPS $(0.27) Misses $(0.25) Estimate

Management

Open Lending Appoints Jessica Buss As CEO And Michelle Glasl As COO, Effective Immediately

Tucker served as interim CEO since February 2025 after being hired as chief financial officer for the company in November 2024, which followed a previous tenure as CFO of Jack in the Box from March 2018 to September 2020.
 &nbsp;

JACK

Jack In The Box Names Lance Tucker As CEO; Tucker Served As Interim CEO Since February 2025

Omeros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMER#NASDAQ">OMER</a>) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.82) by 23.17 percent. This is unchanged from the same period last year.

OMER

Omeros Q4 2024 GAAP EPS $(0.63) Beats $(0.82) Estimate

Construction is scheduled to begin in Summer 2025 with substantial completion anticipated in Spring 2030.
 &nbsp;

Contracts

Fluor Secures Construction Contract For The State Highway 6 Project In College Station, Texas; To Recognize The $671M Bid-Build Contract In Q1 Of 2025

RCAT

Red Cat Holdings 2024 Transition Period EPS $(0.57); Revenue $4.9M

GDEV

GDEV Q4 Revenue $98M Down From $109M QoQ.

TransCon CNP is an investigational prodrug of C-type natriuretic peptide (CNP) administered once weekly and designed to treat individuals with achondroplasia by providing continuous exposure of active CNP to receptors on tissues throughout the body, including growth plates and skeletal muscle.

ASND

Ascendis Submits New Drug Application To FDA For TransCon CNP For Treatment Of Children With Achondroplasia.

In the last three months, 8 analysts have published ratings on The Hartford Insurance Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>), offering a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $132.5, along with a high estimate of $140.00 and a low estimate of $125.00. This current average reflects an increase of 1.44% from the previous average price target of $130.62. 
<img src="https://www.benzinga.com/files/images/story/2025/1743451282_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive The Hartford Insurance Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>C. Gregory Peters</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$135.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$140.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Paul Newsome</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$126.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$139.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$130.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to The Hartford Insurance Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of The Hartford Insurance Gr compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of The Hartford Insurance Gr's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of The Hartford Insurance Gr's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HIG/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on The Hartford Insurance Gr analyst ratings.</a>
<h2>Unveiling the Story Behind The Hartford Insurance Gr</h2>
The Hartford Insurance Group Inc. provides property and casualty insurance, group benefits, and mutual funds. The company is widely recognized for its service excellence, sustainability practices, trust, and integrity. The Company currently conducts business principally in five reportable segments including Business Insurance, Personal Insurance, Property &amp; Casualty Other Operations, Employee Benefits, and Hartford Funds, as well as a Corporate category. The company generates a majority of its revenue from Business Insurance.
<h3>The Hartford Insurance Gr: Financial Performance Dissected</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: The Hartford Insurance Gr's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 7.54%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: The Hartford Insurance Gr's net margin is impressive, surpassing industry averages. With a net margin of 12.47%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The Hartford Insurance Gr's ROE stands out, surpassing industry averages. With an impressive ROE of 5.17%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The Hartford Insurance Gr's ROA stands out, surpassing industry averages. With an impressive ROA of 1.05%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.27, The Hartford Insurance Gr adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

Assessing The Hartford Insurance Gr: Insights From 8 Financial Analysts

Press Releases

Affirm CFO to Answer Investor Questions in Fireside Chat with Stocktwits

StockX and Affirm partner to offer new, transparent payment offering

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Affirm Holdings, Inc - AFRM

Affirm Expands Credit Reporting with Experian to Include All Pay-Over-Time Products

Fintech

FuturHealth Launches Affirm to Offer a Flexible, Transparent Way to Pay Over Time for GLP-1 Medications and Wellness Solutions

Affirm inks deal with J.P. Morgan Payments to deliver more flexible, transparent payments to merchants

Legal

AFRM

AvidXchange Holdings, Inc. - Common Stock

AvidXchange Holdings

Corpay

DLocal

Euronet Worldwide

Evertec

Fiserv

Fidelity National Information Services, Inc. Common Stock

Fidelity National Info

Flywire Corporation - Voting Common Stock

Flywire

Shift4 Payments, Inc. Class A Common Stock

Shift4 Payments

Global Payments

Jack Henry & Associates, Inc. - Common Stock

Jack Henry & Associates

Mastercard

Marqeta

NCR Atleos

PagSeguro Digital Ltd. Class A Common Shares

PagSeguro Digital

Paymentus Holdings, Inc. Class A Common Stock

Paymentus Holdings

Payoneer Global

PayPal Holdings

Remitly Global

StoneCo

Toast

Visa

Western Union

Block

BMO Capital

Compass Point

Goldman Sachs

Barclays

RBC Capital

AAPL

Affirm&#39;s underwriting is more sophisticated than other fintechs and the company has a strong track record, Will Nance said in the initiation note.

Comments

Affirm Holdings

Actualités

Dernières nouvelles pour Affirm Holdings (NASDAQ:AFRM) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL